135 related articles for article (PubMed ID: 24972931)
1. A case with a cytogenetically cryptic variant of the inv(16)(p13q22)/t(16;16)(p13;q22).
Van Obbergh F; Michaux L; Maertens J; Schoemans H; Vandenberghe P
Cancer Genet; 2014 May; 207(5):231-2. PubMed ID: 24972931
[No Abstract] [Full Text] [Related]
2. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of adult patients treated for acute myeloid leukemia with inv 16 in Casablanca (Morocco).
Houssou B; Lamchahab M; Massi R; Oukkache B; Quessar A
Bull Cancer; 2018 Jun; 105(6):552-555. PubMed ID: 29735159
[No Abstract] [Full Text] [Related]
4. Deletion of 3'CBFbeta in an inv(16)(p13.lq22) ascertained by fluorescence in situ hybridization and reverse-transcriptase polymerase chain reaction.
Hung D; St Heaps L; Benson W; Mirochnik O; Sharma P; Smith A
Cancer Genet Cytogenet; 2007 Jan; 172(1):92-4. PubMed ID: 17175390
[No Abstract] [Full Text] [Related]
5. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
[TBL] [Abstract][Full Text] [Related]
6. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
[TBL] [Abstract][Full Text] [Related]
7. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.
van der Reijden BA; Martinet D; Dauwerse JG; Giles RH; Wessels JW; Beverstock GC; Smit B; Mühlematter D; Jotterand Bellomo M; Gabert J; Lafage-Pochitaloff M; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
Leukemia; 1996 Sep; 10(9):1459-62. PubMed ID: 8751463
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of inversion 16 and the Philadelphia chromosome in acute and chronic myeloid leukemias : report of six cases and review of literature.
Wu Y; Slovak ML; Snyder DS; Arber DA
Am J Clin Pathol; 2006 Feb; 125(2):260-6. PubMed ID: 16393682
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetically masked
Ducourneau B; Fenwarth L; Duployez N; Lambert J; Struski S; Luquet I; Daudignon A; Helevaut N; Ruminy P; Preudhomme C; Terre C
Leuk Lymphoma; 2020 Jul; 61(7):1772-1774. PubMed ID: 32223488
[No Abstract] [Full Text] [Related]
10. Emerging therapies for inv(16) AML.
Surapally S; Tenen DG; Pulikkan JA
Blood; 2021 May; 137(19):2579-2584. PubMed ID: 33821975
[TBL] [Abstract][Full Text] [Related]
11. Incidental identification of inv(16)(p13.1q22)/
Quesada AE; Luthra R; Jabbour E; Patel KP; Khoury JD; Tang Z; Alvarez H; Mallampati S; Garcia-Manero G; Montalban-Bravo G; Medeiros LJ; Kanagal-Shamanna R
Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117074
[TBL] [Abstract][Full Text] [Related]
12. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
[TBL] [Abstract][Full Text] [Related]
13. Synchronous Diagnosis of
Shoyele O; Gupta G
Ann Clin Lab Sci; 2018 Nov; 48(6):790-796. PubMed ID: 30610052
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
[TBL] [Abstract][Full Text] [Related]
15. Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).
Markus J; Garin MT; Bies J; Galili N; Raza A; Thirman MJ; Le Beau MM; Rowley JD; Liu PP; Wolff L
Cancer Res; 2007 Feb; 67(3):992-1000. PubMed ID: 17283131
[TBL] [Abstract][Full Text] [Related]
16. Inverted and deleted chromosome 16 with deletion of 3'CBFB identified by fluorescence in situ hybridization.
Spencer DV; Cavalier M; Kalpatthi R; Quigley DI
Cancer Genet Cytogenet; 2007 Nov; 179(1):82-4. PubMed ID: 17981221
[No Abstract] [Full Text] [Related]
17. Novel missense mutations in the tyrosine kinase domain of the platelet-derived growth factor receptor alpha(PDGFRA) gene in childhood acute myeloid leukemia with t(8;21)(q22;q22) or inv(16)(p13q22).
Hiwatari M; Taki T; Tsuchida M; Hanada R; Hongo T; Sako M; Hayashi Y
Leukemia; 2005 Mar; 19(3):476-7. PubMed ID: 15674355
[No Abstract] [Full Text] [Related]
18. Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
Kobayashi T; Ichikawa M; Kamikubo Y; Kurokawa M
Int J Clin Exp Pathol; 2013; 6(1):110-2. PubMed ID: 23236551
[TBL] [Abstract][Full Text] [Related]
19. Core binding factor acute myeloid leukemia.
Paschka P
Semin Oncol; 2008 Aug; 35(4):410-7. PubMed ID: 18692691
[TBL] [Abstract][Full Text] [Related]
20. Characterization of leukemia progression in the Cbfb-MYH11 knockin mice by single cell RNA sequencing.
Diemer JL; Yu K; Kelly M; Zhen T; Anderson S; Lopez G; Liu P
Leukemia; 2023 Jul; 37(7):1549-1553. PubMed ID: 37225965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
